Vulvovaginal Candidiasis (Thrush)
[!WARNING] Medical Disclaimer: This content is for educational and informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional for diagnosis and treatment. Medical guidelines and best practices change rapidly; users should verify information with current local protocols.
Summary
Vulvovaginal Candidiasis (VVC) is an inflammatory condition of the lower genital tract caused by fungal infection, predominantly Candida species. It is an extremely common source of morbidity, affecting 75% of women of reproductive age at least once in their lifetime. Recurrent VVC (RVVC) affects 5-8% of women and can be psychologically devastating.
Unlike Chlamydia or Gonorrhea, VVC is NOT classified as a Sexually Transmitted Infection (STI). It is an Endogenous Infection caused by the overgrowth of commensal flora. However, sexual activity can be a trigger (micro-trauma).
The Classification (Sobel Classification)
We divide VVC into two clinical entities because the management is completely different:
- Uncomplicated VVC:
- Sporadic/Infrequent (<3 episodes/year).
- Mild-Moderate symptoms.
- Susceptible organism (C. albicans).
- Healthy, non-pregnant host.
- Complicated VVC:
- Recurrent (4+ episodes/year).
- Severe (Extensive erythema/fissuring).
- Non-albicans (C. glabrata, C. krusei).
- Compromised host (Diabetes, HIV, Pregnancy).
Key Facts Table
| Feature | Uncomplicated | Complicated |
|---|---|---|
| Prevalence | 90% | 10% |
| Pathogen | C. albicans | C. albicans or Non-albicans |
| Host | Healthy | Diabetic/Immunosuppressed |
| Treatment | Short course (1-3 days) | Long course (7-14 days) |
| Response | Rapid (>90% cure) | Slow / Incomplete |
Incidence
- Lifetime Risk: 75% of women.
- Recurrent Risk: 5-8% of women experience RVVC.
- Age: Peak incidence 20-40 years. Rare before menarche (oestrogen dependent) and rare after menopause (unless on HRT).
Risk Factors (The "Candida Triggers")
- Antibiotics: The most common trigger. Broad-spectrum agents (Amoxicillin, Cephalosporins) kill the protective Lactobacillus species.
- Mechanism: Lactobacilli produce hydrogen peroxide and bacteriocins that inhibit yeast. Killing them removes the "policeman".
- High Oestrogen States:
- Pregnancy: High risk in 3rd trimester (high glycogen in vaginal mucosa).
- COCP/HRT: Especially high-dose pills.
- Mechanism: Oestrogen increases vaginal glycogen (yeast food) and upregulates Candida avidity receptors.
- Diabetes Mellitus:
- Specifically Uncontrolled Diabetes.
- Mechanism: Hyperglycaemia impairs neutrophil phagocytosis and provides glucose substrate for fungal growth.
- Pearl: SGLT-2 Inhibitors (e.g., Dapagliflozin) cause glycosuria and massively increase VVC risk.
- Immunosuppression:
- HIV (Low CD4 count).
- Corticosteroids (Inhalers or systemic).
- Behavioral:
- Tight synthetic clothing (heat/moisture trap).
- Vaginal Douching (Disrupts microbiome).
The Organism
- Candida albicans (85-90%):
- Dimorphic fungus.
- Exist as Blastospores (Budding yeast) in the asymptomatic carrier state.
- Transform into Hyphae (Mycelia) in the invasive disease state.
- Hyphae invade the superficial epithelium, triggering inflammation.
- Candida glabrata (5-10%):
- Non-dimorphic (Yeast form only).
- Low virulence (milder symptoms).
- High Resistance: Often resistant to Azoles.
- Candida krusei (<1%):
- Intrinsically Resistant to Fluconazole. (Target requires different drugs).
The Immune Response
Why do some women get RVVC?
- It is not usually "Antibody Deficiency". Women with RVVC have normal systemic immunity.
- It is a Local Mucosal Dysregulation.
- Th1 vs Th2: Effective clearance requires a Th1 (Cellular) response. Women with RVVC may mount an inappropriate Th2 (Allergic/Antibody) response, which fails to clear the fungus and leads to chronic inflammation.
- Genetic Susceptibility: Polymorphisms in Mannose-Binding Lectin (MBL) and Toll-Like Receptors (TLR2/4) are linked to RVVC.
Symptoms
- Pruritus (90%): The cardinal symptom. Can be maddeningly intense, interfering with sleep.
- Soreness/Burning: Often worse after micturition (dysuria) due to acidic urine hitting inflamed skin ("External Dysuria").
- Discharge:
- Classic: "Cottage Cheese" (Thick, white, curdy, clumpy).
- Variant: Watery/Thin.
- Pearl: Usually Odorless. If there is a "fishy" smell, it is Bacterial Vaginosis (BV), not Thrush.
- Dyspareunia: Superficial pain during intercourse due to friction on inflamed tissues.
Signs
- Vulvitis: Erythema (redness), Oedema (swelling) of labia minora/majora.
- Fissuring: Deep, painful cracks in the posterior fourchette or interlabial sulcus.
- Excoriation: Scratch marks (secondary to itch).
- Vaginitis: Red vaginal walls with adherent white plaques.
- Satellite Lesions: Small pustules extending to the groin/inner thigh (indicates severe cutaneous candidiasis).
Differential Diagnosis
Before treating for "Thrush for the 10th time", consider mimics:
- Bacterial Vaginosis (BV): Grey discharge, Fishy Order, pH >4.5.
- Trichomoniasis: Green/Yellow frothy discharge, Strawberry cervix.
- Cytolytic Vaginosis: Overgrowth of Lactobacilli. Symptoms identical to thrush (itch/burn) but pH Low (3.5-4.5) and Microscopy shows lysis. Antifungals make it worse. Treatment is baking soda baths.
- Lichen Sclerosus: White atrophic patches, figure-of-8 pattern. Itch is main symptom. Needs steroids.
- Plasma Cell Vulvitis: Shiny red patches. Rare.
- Contact Dermatitis: Reaction to perfumes, soaps, or antifungal creams themselves!
Examination
- Vulval Inspection: Look for fissures/erythema.
- Speculum: Essential to visualise the vaginal walls and cervix. (Don't just swab the outside!).
Bedside Tests
- pH Testing (The Most Useful Tool):
- Place pH paper on the vaginal wall (lateral fornix).
- pH < 4.5 (Acidic): Consistent with Candida (or normal).
- pH > 4.5 (Basic): Bacterial Vaginosis or Trichomonas.
- Rule: If itch + pH >5, it is NOT uncomplicated thrush. Look for mixed infection.
- Wet Mount Microscopy:
- Saline slide: Shows budding yeast.
- 10% Low (Potassium Hydroxide): Lyses epithelial cells, making Hyphae visible.
- Sensitivity: 50-70% (Microscopy misses 30% of cases!).
Laboratory Tests
- High Vaginal Swab (HVS) for Culture:
- Indication: Complicated VVC, Recurrent VVC, Treatment failure.
- Goal: Identify species (glabrata vs albicans) and sensitivity.
- Note: PCR swabs are becoming available but Culture remains gold standard for sensitivity testing.
- HbA1c: Mandatory in any woman with Recurrent VVC.
- HIV Test: In severe/recalcitrant cases.
Uncomplicated VVC
"Treat the patient, not the swab." Only treat asymptomatic carriage if pregnancy is a factor? No, asymptomatic carriage needs NO treatment.
Options (Equally Effective):
- Oral: Fluconazole 150mg Single Dose.
- Pros: Convenient, less mess.
- Cons: GI upset, drug interactions, takes 24h to work.
- Topical: Clotrimazole (Canesten).
- Pessary: 500mg Single Dose.
- Cream: 10% Single Dose or 2% for 3 nights.
- Pros: Instant soothing action, safe in pregnancy.
- Cons: Messy, can weaken condoms.
Severe VVC (Extensive inflammation/Fissures)
Single dose is insufficient.
- Regimen: Fluconazole 150mg Day 1 and Day 4. (Two doses).
- Adjunct: Topical Hydrocortisone/Clotrimazole combo (Canesten HC) to reduce vulval swelling/itch quickly.
Pregnancy
- Contraindication: Oral Fluconazole is associated with miscarriage and congenital heart defects (Tetralogy of Fallot) in high doses. Avoid in 1st trimester.
- Treatment: Topical Clotrimazole.
- Duration: 7 nights usually required (recurrence is high due to hormones).
Recurrent VVC (RVVC)
Definition: 4+ episodes / year. The "Sobel Regimen" (Induction & Maintenance) is the global standard.
Phase 1: Induction (Getting control)
- Fluconazole 150mg every 72 hours for 3 doses (Day 1, 4, 7).
- Goal: Mycological cure (Negative culture).
Phase 2: Maintenance (Suppression)
- Fluconazole 150mg Once Weekly for 6 months.
- Evidence: Reduces recurrence rate from 50% to <10% while on treatment.
- Relapse: Occurs in 40-50% os women after stopping the 6-month course. Can extend to 1 year if needed.
- Liver Safety: Check LFTs if continuing beyond 6 months (rarely hepatotoxic).
Candida Glabrata (Azole Resistant)
Fluconazole will fail.
- First Line: Nystatin Pessaries 100,000 units daily for 14 days. (Polyene antifungal).
- Second Line: Boric Acid Suppositories 600mg daily for 14-21 days.
- Mechanism: Unknown, but highly effective against non-albicans species.
- WARNING: Boric Acid is FATAL IF SWALLOWED. Must be labelled "For Vaginal Use Only". Keep away from children. Never use in pregnancy.
- Third Line: Flucytosine cream (Specialist formulation).
- Secondary Infection: "Scratch-Itch Cycle" leads to microscopic skin breaks -> Staph Aureus superinfection (Cellulitis/Abscess).
- Vaginismus: Chronic pain leads to fear of penetration. Pelvic floor spasm. Needs psychosexual therapy even after yeast is cleared.
- Neonatal Transmission: Oral thrush (white tongue) in baby.
- Systemic Candidiasis: In profoundly immunosuppressed patients (Chemo/AIDS), vaginal candida can be a portal for candidaemia (high mortality).
Does diet help?
- Sugar: Cutting refined sugar helps in theory (yeast loves glucose), and is crucial for Diabetics. Evidence in euglycaemic women is weak but anecdotal success is high.
- Probiotics:
- Oral Lactobacillus: Mixed evidence.
- Vaginal Lactobacillus (Pessaries): Can help restore flora after antibiotics.
- Verdict: No harm, possible benefit.
- Hygiene:
- Avoid soaps/shower gels (alkaline pH allows yeast to thrive).
- Use Emollients (E45/Aqueous cream) as soap substitute.
- Cotton underwear (breathable).
- Avoid tight jeans/leggings.
- Partners: Do NOT treat male partners unless symptomatic (Balanitis - itchy penis). Sexual transmission is not the main driver.
BASHH 2019 Guidelines
- Recommend HVS for all recurrent cases.
- Advocate Sobel Regimen for RVVC.
- Highlight Boric Acid for Glabrata.
CDC 2021 Guidelines
- Emphasize typing of Candida species.
- Warn against self-diagnosis (women are wrong 50% of the time - often it's BV).
Key Papers
- Sobel JD et al (NEJM 2004): The landmark RCT proving weekly fluconazole works for maintenance. n=387. Recurrence 6.7% vs 50% in placebo.
- Azole: Class of antifungals (Fluconazole, Clotrimazole) inhibiting ergosterol synthesis.
- Blastospore: The yeast form of Candida (non-invasive).
- Commensal: An organism living harmlessly on the host.
- Dyspareunia: Painful sex.
- Hyphae: The branching, invasive form of Candida.
- Pessary: A tablet inserted into the vagina.
- SGLT-2: Diabetes drug class (Gliflozins) that causes glycosuria. Massive thrush risk.
- Sobel JD. Vulvovaginal candidosis. Lancet. 2007;369(9577):1961-71.
- Sherrard J, et al. European (IUSTI/WHO) Guideline on the Management of Vaginal Discharge. Int J STD AIDS. 2018.
- BASHH. UK National Guideline on the Management of Vulvovaginal Candidiasis. 2019.
- CDC. Sexually Transmitted Infections Treatment Guidelines. 2021.
- Achkar JM, Fries BC. Candida infections of the genitourinary tract. Clin Microbiol Rev. 2010.
| ID | Description | Section | Priority |
|---|---|---|---|
| IMG-VVC-01 | Microscopy: Wet mount showing Hyphae and Spores. | 5. Diagnosis | High |
| IMG-VVC-02 | Clinical sign: Curdy white discharge ("Cottage Cheese"). | 4. Presentation | High |
| IMG-VVC-03 | Satellite Lesions: Pustules on inner thigh. | 4. Presentation | Medium |
| IMG-VVC-04 | Lichen Sclerosus: Differential diagnosis (White patches). | 4. Differential | High |
| IMG-VVC-05 | Management Algorithm: Flowchart (Uncomplicated vs Complicated). | 6. Management | High |
(End of File)